Chondroitin sulphate reduces both cartilage volume loss and bone marrow lesions in knee osteoarthritis patients starting as early as 6 months after initiation of therapy: a randomised, double-blind, placebo-controlled pilot study using MRI

OBJECTIVE: To determine the effect of chondroitin sulphate (CS) treatment on cartilage volume loss, subchondral bone marrow lesions (BML), synovitis and disease symptoms in patients with knee osteoarthritis (OA). METHODS: In this pilot multicentre, randomised, double-blind, controlled trial in prima...

Descripción completa

Detalles Bibliográficos
Autores principales: Wildi, Lukas Martin, Raynauld, Jean-Pierre, Martel-Pelletier, Johanne, Beaulieu, André, Bessette, Louis, Morin, Frédéric, Abram, François, Dorais, Marc, Pelletier, Jean-Pierre
Formato: Texto
Lenguaje:English
Publicado: BMJ Group 2011
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3086081/
https://www.ncbi.nlm.nih.gov/pubmed/21367761
http://dx.doi.org/10.1136/ard.2010.140848

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3086081/
https://www.ncbi.nlm.nih.gov/pubmed/21367761
http://dx.doi.org/10.1136/ard.2010.140848

Ejemplares similares